Copy to clipboard 
Nexus Spine shared pilot study results of a comparative radiographic assessment of ACDF outcomes in a series of patients who were selected for common risk factors of subsidence, instability, and delayed bone growth. Specifically, the patients were over 66 years of age, had poor bone quality, and/or required cervical fusion surgery at three or more contiguous levels. Each patient received a Nexus Spine Tranquil® cervical interbody cage at one or more spinal levels, and, as a control, some patients received one or more competing interbody devices at adjacent level(s).
Post-operative radiographic assessment of the treated levels at each of two weeks, six weeks, six months, and twelve months revealed that the levels treated with Nexus Spine’s Tranquil interbody devices had no measurable subsidence. In contrast, the levels treated with the other interbody devices demonstrated measurable subsidence as soon as two weeks in more than 66% of the levels treated. Subsidence is a primary indicator of spinal instability and pain. Accordingly, the results of this study suggest that Nexus Spine’s patented technology amounts to a significant improvement over the competing devices.
Peer-reviewed publications demonstrate competitive devices that exhibit at least 3 mm of subsidence in more than 52% of patients. Nexus Spine’s Tranquil interbody cages performed much better, with no subsidence.
“If we can solve the key challenges for the highest-risk patients,” said David Hawkes, President of Nexus Spine, “then we can improve the universal standard of care.” David further explained, “Matching the stiffness of the host bone is key. This pilot study is very exciting because it demonstrates that our patented Tranquil interbody implants are better at preventing subsidence. We are also looking at how much faster our devices provide stability. Subsidence and prolonged instability are both consequences of using an interbody that is too stiff.”
Source: Nexus Spine
Nexus Spine shared pilot study results of a comparative radiographic assessment of ACDF outcomes in a series of patients who were selected for common risk factors of subsidence, instability, and delayed bone growth. Specifically, the patients were over 66 years of age, had poor bone quality, and/or required cervical fusion surgery at three or...
Nexus Spine shared pilot study results of a comparative radiographic assessment of ACDF outcomes in a series of patients who were selected for common risk factors of subsidence, instability, and delayed bone growth. Specifically, the patients were over 66 years of age, had poor bone quality, and/or required cervical fusion surgery at three or more contiguous levels. Each patient received a Nexus Spine Tranquil® cervical interbody cage at one or more spinal levels, and, as a control, some patients received one or more competing interbody devices at adjacent level(s).
Post-operative radiographic assessment of the treated levels at each of two weeks, six weeks, six months, and twelve months revealed that the levels treated with Nexus Spine’s Tranquil interbody devices had no measurable subsidence. In contrast, the levels treated with the other interbody devices demonstrated measurable subsidence as soon as two weeks in more than 66% of the levels treated. Subsidence is a primary indicator of spinal instability and pain. Accordingly, the results of this study suggest that Nexus Spine’s patented technology amounts to a significant improvement over the competing devices.
Peer-reviewed publications demonstrate competitive devices that exhibit at least 3 mm of subsidence in more than 52% of patients. Nexus Spine’s Tranquil interbody cages performed much better, with no subsidence.
“If we can solve the key challenges for the highest-risk patients,” said David Hawkes, President of Nexus Spine, “then we can improve the universal standard of care.” David further explained, “Matching the stiffness of the host bone is key. This pilot study is very exciting because it demonstrates that our patented Tranquil interbody implants are better at preventing subsidence. We are also looking at how much faster our devices provide stability. Subsidence and prolonged instability are both consequences of using an interbody that is too stiff.”
Source: Nexus Spine
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
